Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases

Endocrinology

Volumn 149, Issue 2, 2008, Pages 483-491

  Park, Kwijun ^a   Itoh, Hiroshi ^a,b   Yamahara, Kenichi ^a   Sone, Masakatsu ^a   Miyashita, Kazutoshi ^a   Oyamada, Naofumi ^a   Sawada, Naoya ^a   Taura, Daisuke ^a   Inuzuka, Megumi ^a   Sonoyama, Takuhiro ^a   Tsujimoto, Hirokazu ^a   Fukunaga, Yasutomo ^a   Tamura, Naohisa ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; STREPTOZOCIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LEG ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTERIOSCLEROSIS OBLITERANS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; FEMALE; FOOT ULCER; GANGRENE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; REGIONAL BLOOD FLOW; THROMBOANGIITIS OBLITERANS; TREATMENT OUTCOME;

EID: 38549171466     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1094     Document Type: Article

References (30)

1. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM 1999 Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355-363
2. Martin A, Komada MR, Sane DC 2003 Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23:117-145
3. Tesfamariam B, Cohen RA 1992 Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326
4. Tamura N, Chrisman TD, Garbers DL 2001 The regulation and physiological roles of the guanylyl cyclase receptors. Endocr J 48:611-634
5. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC 1997 Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95:2068-2074
6. Sugawara A, Nakao K, Morii N, Yamada T, Itoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Nishimura K, Obata K, Yasue H, Ban T, ImuraH1988 Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP. J Clin Invest 81:1962-1970
7. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inoue K, Imura H 1991 Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402-1412
8. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130:229-239
9. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH 2000 Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 343:246-253
10. Suwa M, Seino Y, Nomachi Y, Matsuki S, Funahashi K 2005 Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy. Circ J 69:283-290
11. Kook H, Itoh H, Choi BS, Sawada N, Doi K, Hwang TJ, Kim KK, Arai H, Baik YH, Nakao K 2003 Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am J Physiol Heart Circ Physiol 284:H1388-H1397
12. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K 1994 Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93:1911-1921
13. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F 1998 Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17:3045-3051
14. Yamahara K, Itoh H, Chun TH, Ogawa Y, Yamashita J, Sawada N, Fukunaga Y, Sone M, Yurugi-Kobayashi T, Miyashita K, Tsujimoto H, Kook H, Feil R, Garbers DL, Hofmann F, NakaoK 2003 Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci USA 100:3404-3409
15. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. Possible existence of "vascular natriuretic peptide system". J Clin Invest 90:1145-1149
16. Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y, Yamashita J, Chun TH, Inoue, M, Masatsugu K, Sawada N, Fukunaga Y, Saito T, Sone M, Yamahara K, Kook H, Komeda M, Ueda M, Nakao K 2001 C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol 21:930-936
17. Ohno N, Itoh H, Ikeda T, Ueyama K, Yamahara K, Doi K, Yamashita J, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Sakaguchi S, Sone M, Yurugi T, Kook H, Komeda M, Nakao K 2002 Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 105:1623-1626
18. Naruko T, Ueda M, van der Wal AC, van der Loos CM, Itoh H, Nakao K, Becker AE 1996 C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation 94:3103-3108
19. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M 1996 Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270:H411-H415
20. Hood J, Granger HJ 1998 Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 273:23504-23508
21. Ceriello A, Motz E 2004 Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816-823
22. Kielstein JT, Zoccali C 2005 Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 46:186-202
23. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ 2003 Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci USA 100:1426-1431
24. Ingwersen SH, Jorgensen PN, Eiskjaer H, Johansen NL, Madsen K, Faarup P 1992 Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor. J Immunol Methods 149:237-246
25. Kiemer AK, Vollmar AM 2001 The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis 60(Suppl 3):68-70
26. Scotland RS, Cohen M, Foster P, Lovell M, Mathur A, Ahluwalia A, Hobbs AJ 2005 C-type natriuretic peptide inhibits leukocyte recruitment and plateletleukocyte interactions via suppression of P-selectin expression. Proc Natl Acad Sci USA 102:14452-14457
27. Tamura N, Doolittle LK, Hammer RE, Shelton JM, Richardson JA, Garbers DL 2004 Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci USA 101:17300-17305
28. Acuff CG, Huang H, Steinhelper ME 1997 Estradiol induces C-type natriuretic peptide gene expression in mouse uterus. Am J Physiol 273:H2672-2677
29. Coats P, Wadsworth R 2005 Marriage of resistance and conduit arteries breeds critical limb ischemia. Am J Physiol Heart Circ Physiol 288:H1044-H1050
30. Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, KuhnM2005 Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115:1666-1674